Incretin-based therapy for diabetes prevention in patients with obesity In agreement with what has been previously shown for any weight-lowering lifestyle intervention and medication, regardless of their mechanism of action 18 , incretin-based AOM have been associated with amelioration of glucose metabolism and T2D prevention (Fig
Gydesen S
This comprehensive, systems-oriented viewpoint promotes fundamental shifts towards proactive, mechanism-focused initiatives that enhance and will continue to advance our comprehension of positive, healthy aging, as outlined in Table 4, which highlights critical knowledge gaps and outlines actionable future research directions for GLP-1 RAs in promoting healthy aging
The reason for this name is because Tirzepatide targets both GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory polypeptide) receptors in the body
EllieMD Best for microdosing, longevity, and gentle weight support
No published case reports document this mechanism causing clinical harm, but the pharmacokinetic logic supports conservative dosing in this scenario
